Condition

T-ALL clinical trials and research

As of November 12, 2026, Find a Trial lists 3 T-ALL clinical trials that are recruiting, at sites in 3 countries (most in United States (1), Germany (1), China (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest T-ALL clinical trials

StudyPhaseWhereStatusRegistered
Treatment for CD38 Positive T-cell Acute Lymphoblastic Leukemia Phase 2 Augsburg and 14 other locations Recruiting Oct 18, 2024
CAR-T therapy for adults with relapsed or refractory T-lymphoblastic lymphoma or leukemia Phase 1 Shanghai Recruiting Nov 18, 2023
CD123-CAR T-cell therapy for treating acute myeloid leukemia and related conditions Phase 1 Memphis, Tennessee and 1 other locations Recruiting Mar 24, 2020

All recruiting trials (3)

Related topics

AML/MDSB-ALLBPDCNT-lymphoblastic LymphomaCAR-TIsatuximab

Quick answers

How many T-ALL clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (1 trial), Germany (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.